CD19 CAR Lentivirus

Our CD19 CAR Lentivirus is developed to target specifically on CD19 protein which is an important biomarker in B-cell malignancies. This vector is the pillar of many leukemias and lymphomas treatments and a ray of hope for patients diagnosed with these types of cancer.

Check the CAR-T Cell Preparation-Lentivirus Packaging Service

Order information

Description

CD19 CAR Lentivirus is innovative cancer therapy targeting B-cell malignancies, which is developed by GeneMedi and can be considered an innovative solution for the problem. CD19 is a protein present uniformly on the surface of B cells and has rather recently become a prominent target for CAR-T cell therapies owing to its expression on B cell leukemias and lymphomas. Our CD19 CAR Lentivirus offers scientific researchers a suitable system to apply T cell gene therapy and enhance the targeting and killing of cancer cells that have CD19 markers.

The structure of lentiviral vector that we used for creating our CD19 CAR is the culmination of expansive study and fine tuning. Afterwards T cells are modified and made to carry a chimeric antigen receptor which targets the CD19 antigen causing the cytotoxic action of the cell to be activated. This approach has not only been proven effective in clinical trials, but also raised the hope of survival for people battling previously untreatable forms of leukaemia and lymphoma like ALL.

Hence, GeneMedi has designed the CD19 CAR Lentivirus to be produced to sectors that require quality therapeutic products. je is especially important today to follow exacting standards in the production process to guard the purity, potency, and safety of a product. The chosen genus of lentiviruses is to be a rather universal vector for different investigation and therapeutic needs, thus helping create individualized approaches to treatment. Getting on this note, our CD19 CAR Lentivirus breaks the barriers that come with the volative nature of new treatment forms in immune oncology.

Validation Data

Figure 1. GM-Lenti-CAR Lentivirus represent a great performence in CAR-expression